| scholarly article | Q13442814 |
| P50 | author | Jaap Jan Boelens | Q47093637 |
| Debbie van Baarle | Q100532618 | ||
| P2093 | author name string | Elisabeth A M Sanders | |
| Henk Visscher | |||
| Anton M van Loon | |||
| Cuno S P M Uiterwaal | |||
| Rob Schuurman | |||
| Marc Bierings | |||
| Machiel de Vos | |||
| P J Anne de Pagter | |||
| P433 | issue | 7 | |
| P921 | main subject | risk factor | Q1475848 |
| P304 | page(s) | 831-839 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome | |
| P478 | volume | 14 |
| Q37601730 | A combined biomarker and clinical panel for chronic graft versus host disease diagnosis |
| Q34273968 | Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT. |
| Q40213229 | Analysis of human herpes virus 6 infections with a quantitative, standardized, commercial kit in pediatric stem cell transplant recipients after transplantation |
| Q27028006 | Antiviral T-cell therapy |
| Q37687412 | Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation |
| Q54435011 | Different cytokine signatures in children with localized and invasive adenovirus infection after stem cell transplantation. |
| Q58605816 | Effects of HLA mismatch on cytomegalovirus reactivation in cord blood transplantation |
| Q35154802 | Effects of nutritional supplementation on fatigue, and autonomic and immune dysfunction in patients with end-stage renal disease: a randomized, double-blind, placebo-controlled, multicenter trial |
| Q38231549 | Encephalitis caused by human herpesvirus-6B in pancreas-after-kidney transplantation. |
| Q33559473 | Epidemiology and potential preventative measures for viral infections in children with malignancy and those undergoing hematopoietic cell transplantation |
| Q40346711 | Epidemiology of Multiple Herpes Viremia in Previously Immunocompetent Patients With Septic Shock |
| Q33897804 | Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin |
| Q92993210 | Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation |
| Q37618303 | HHV-6 encephalitis in pediatric unrelated umbilical cord transplantation: a role for ganciclovir prophylaxis? |
| Q38045704 | HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis |
| Q28727925 | HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation |
| Q47572113 | High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality |
| Q45350735 | Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT. |
| Q35774717 | Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary? |
| Q42219821 | Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease |
| Q42234693 | Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen |
| Q41021152 | Human herpesvirus-6 viremia is not associated with poor clinical outcomes in children following allogeneic hematopoietic cell transplantation |
| Q40884483 | Identification of novel CD8+ T cell epitopes in human herpesvirus 6B U11 and U90. |
| Q37006823 | Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation |
| Q41758098 | Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation |
| Q33819076 | Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases |
| Q42228544 | Multicenter external quality assessment of molecular methods for detection of human herpesvirus 6. |
| Q33713932 | Nucleofection of DCs to generate Multivirus-specific T cells for prevention or treatment of viral infections in the immunocompromised host. |
| Q35849274 | Optimisation of a quantitative polymerase chain reaction-based strategy for the detection and quantification of human herpesvirus 6 DNA in patients undergoing allogeneic haematopoietic stem cell transplantation. |
| Q30368207 | Prevalence and risk factors for betaherpesvirus DNAemia in children >3 weeks and <2 years of age admitted to a large referral hospital in sub-Saharan Africa. |
| Q93083451 | Prevalence of human herpesviruses in biliary fluid and their association with biliary complications after liver transplantation |
| Q33767001 | Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications |
| Q47436824 | Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation. |
| Q38256992 | Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials |
| Q49716147 | Significance of PCR detection of HHV6 in gastro biopsy on the course of diarrhea in patients with severe diarrhea after allogeneic hematopoietic stem cell transplantation |
| Q38163428 | The evolving art of hematopoietic stem cell transplantation: translational research in post-transplant immune reconstitution and immunosuppression |
| Q40079621 | Transmission of chromosomally integrated human herpesvirus 6 via cord blood transplantation |
Search more.